Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA mulls compounding for peptides previously flagged over safety risks BioSpace What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner